首页 > 最新文献

Movement Disorders Clinical Practice最新文献

英文 中文
The Benefit of Exclusive Nocturnal Levodopa-Carbidopa Intestinal Infusion for Severe Refractory Sleep Behavior Disorder in Parkinson's Disease. 单独夜间左旋多巴-卡比多巴肠道输注治疗帕金森病严重难治性睡眠行为障碍的益处
IF 2.7 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-07-18 DOI: 10.1002/mdc3.70237
María Rivera-Sánchez, Antonio Sánchez-Rodríguez, Leire Manrique, María Sierra, Isabel González-Aramburu, María Victoria Sánchez-Peláez, Marián Martínez, Anjana López-Delgado, Jon Infante
{"title":"The Benefit of Exclusive Nocturnal Levodopa-Carbidopa Intestinal Infusion for Severe Refractory Sleep Behavior Disorder in Parkinson's Disease.","authors":"María Rivera-Sánchez, Antonio Sánchez-Rodríguez, Leire Manrique, María Sierra, Isabel González-Aramburu, María Victoria Sánchez-Peláez, Marián Martínez, Anjana López-Delgado, Jon Infante","doi":"10.1002/mdc3.70237","DOIUrl":"10.1002/mdc3.70237","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2379-2381"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715335/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144659684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing Variability and Bridging the Gap in Parkinson's Disease Care: A Call to Action. 解决可变性和弥合差距在帕金森病的护理:呼吁采取行动。
IF 2.7 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-07-22 DOI: 10.1002/mdc3.70255
Daniel G Di Luca, Ali Shalash
{"title":"Addressing Variability and Bridging the Gap in Parkinson's Disease Care: A Call to Action.","authors":"Daniel G Di Luca, Ali Shalash","doi":"10.1002/mdc3.70255","DOIUrl":"10.1002/mdc3.70255","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2055-2057"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715327/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144691040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Exploration of the High Prevalence of Parkinson's Disease in a Rural Area of North West England. 英国西北部农村地区帕金森病高患病率的探讨。
IF 2.7 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-08-25 DOI: 10.1002/mdc3.70303
Rosanna Varden, Ailish O'Callaghan, Richard Walker

Background: Globally the prevalence of Idiopathic Parkinson's Disease (IPD) is rising. Increasing recognition is being given to the influence of environmental factors on this rise, although the precise impact of such factors remains poorly understood. We need accurate ways of measuring prevalence to understand regional and global trends.

Objectives: To use case finding methodology to measure the crude, and age adjusted, prevalence of IPD in a rural area of North West England, and to describe the difference in results with those obtained using electronic record searching alone to understand the accuracy of such methods. To compare prevalence between subgroups to build hypotheses that could guide further research.

Methods: Local Parkinson's service records from several sources were searched electronically and manually reviewed against validated diagnostic criteria. Figures were age adjusted according to the national denominator population.

Results: The age adjusted prevalence of IPD was 201/100,000 (95% CI 186-217), higher than in any other published UK study using similar case finding methods. Numbers were higher using electronic diagnostic code searching alone, which may over estimate prevalence. No significant difference was seen between rural and urban areas, relative risk 0.92 (95% CI 0.80-1.06), although there was a trend to higher prevalence in historically industrial coastal areas.

Conclusions: This study highlights some of the pitfalls in using large healthcare datasets to measure IPD prevalence. Overall, the prevalence of IPD is high in this predominantly rural area, and exhibits prevalence trends that warrant further investigation in relation to genetic and environmental factors.

背景:全球特发性帕金森病(IPD)的患病率正在上升。人们日益认识到环境因素对这种上升的影响,尽管对这些因素的确切影响仍然知之甚少。我们需要准确的衡量流行率的方法,以了解区域和全球趋势。目的:使用病例查找方法测量英格兰西北部农村地区的原始和年龄调整后的IPD患病率,并描述结果与单独使用电子记录检索获得的结果的差异,以了解此类方法的准确性。比较亚组之间的患病率,以建立可以指导进一步研究的假设。方法:以电子方式检索来自多个来源的本地帕金森服务记录,并根据验证的诊断标准进行人工审查。数据根据全国分母人口进行年龄调整。结果:经年龄调整的IPD患病率为201/100,000 (95% CI 186-217),高于使用类似病例查找方法的任何其他已发表的英国研究。单独使用电子诊断代码搜索的数字更高,这可能高估了患病率。农村和城市地区之间没有显著差异,相对危险度为0.92 (95% CI 0.80-1.06),尽管在历史上的工业沿海地区有较高流行率的趋势。结论:本研究强调了使用大型医疗数据集测量IPD患病率的一些缺陷。总的来说,IPD的患病率在这个主要是农村地区很高,并且显示出与遗传和环境因素有关的进一步调查的流行趋势。
{"title":"An Exploration of the High Prevalence of Parkinson's Disease in a Rural Area of North West England.","authors":"Rosanna Varden, Ailish O'Callaghan, Richard Walker","doi":"10.1002/mdc3.70303","DOIUrl":"10.1002/mdc3.70303","url":null,"abstract":"<p><strong>Background: </strong>Globally the prevalence of Idiopathic Parkinson's Disease (IPD) is rising. Increasing recognition is being given to the influence of environmental factors on this rise, although the precise impact of such factors remains poorly understood. We need accurate ways of measuring prevalence to understand regional and global trends.</p><p><strong>Objectives: </strong>To use case finding methodology to measure the crude, and age adjusted, prevalence of IPD in a rural area of North West England, and to describe the difference in results with those obtained using electronic record searching alone to understand the accuracy of such methods. To compare prevalence between subgroups to build hypotheses that could guide further research.</p><p><strong>Methods: </strong>Local Parkinson's service records from several sources were searched electronically and manually reviewed against validated diagnostic criteria. Figures were age adjusted according to the national denominator population.</p><p><strong>Results: </strong>The age adjusted prevalence of IPD was 201/100,000 (95% CI 186-217), higher than in any other published UK study using similar case finding methods. Numbers were higher using electronic diagnostic code searching alone, which may over estimate prevalence. No significant difference was seen between rural and urban areas, relative risk 0.92 (95% CI 0.80-1.06), although there was a trend to higher prevalence in historically industrial coastal areas.</p><p><strong>Conclusions: </strong>This study highlights some of the pitfalls in using large healthcare datasets to measure IPD prevalence. Overall, the prevalence of IPD is high in this predominantly rural area, and exhibits prevalence trends that warrant further investigation in relation to genetic and environmental factors.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2304-2310"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144962076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of DBS Outcome by MDS-UPDRS Severity Levels: Comparison with Changes on MDS-UPDRS III. MDS-UPDRS严重程度对DBS预后的分析:与MDS-UPDRS变化的比较
IF 2.7 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-07-22 DOI: 10.1002/mdc3.70244
Sergio A Castillo-Torres, Ivonne Cruz, Malco Rossi, Miguel Wilken, Daniel Cerquetti, Marcelo Merello

Background: MDS-UPDRS Severity Levels (SLs), derived from clinician- and patient-rated scales, remain underused to evaluate response to subthalamic deep brain stimulation (STN-DBS) in patients with Parkinson's disease (PD).

Objectives: To evaluate MDS-UPDRS SL as markers of STN-DBS response.

Methods: SLs were categorized as mild, moderate, or severe using established cut-off points for Parts II, III Off, and IV. Improvement was defined as a decrease in at least one SL. Part III Off improvement was correlated to quality-of-life scales and used to predict SL improvement using ROC Curve analysis.

Results: A total of 51 patients (34.1% female, aged 58.9 ± 10.2 years, disease duration 12.3 ± 4.1 years) were evaluated 12 months after surgery. MDS-UPDRS III Off changes over 30% predicted SL improvements in MDS-UPDRS II (AUC = 0.83, p = 0.015) and IV (AUC = 0.89, p = 0.001).

Conclusion: Our findings suggest that improvement in MDS-UPDRS SL are potential markers of STN-DBS response. With an MDS-UPDRS part III improvement around 30% predicting SL improvement.

背景:MDS-UPDRS严重程度等级(SLs)来源于临床医生和患者评分的量表,但仍未充分用于评估帕金森病(PD)患者对丘脑下深部脑刺激(STN-DBS)的反应。目的:评价MDS-UPDRS SL作为STN-DBS反应的标志物。方法:使用第二部分、第三部分和第四部分的既定截止点将SL分为轻度、中度或重度。改善被定义为至少一种SL的减少。第三部分的改善与生活质量量表相关,并使用ROC曲线分析用于预测SL的改善。结果:术后12个月评估51例患者(女性34.1%,年龄58.9±10.2岁,病程12.3±4.1年)。MDS-UPDRS III的Off变化超过30%预示着MDS-UPDRS II (AUC = 0.83, p = 0.015)和IV (AUC = 0.89, p = 0.001)的SL改善。结论:我们的研究结果表明MDS-UPDRS SL的改善是STN-DBS反应的潜在标志。随着MDS-UPDRS第三部分的改进,大约30%的预测SL改善。
{"title":"Analysis of DBS Outcome by MDS-UPDRS Severity Levels: Comparison with Changes on MDS-UPDRS III.","authors":"Sergio A Castillo-Torres, Ivonne Cruz, Malco Rossi, Miguel Wilken, Daniel Cerquetti, Marcelo Merello","doi":"10.1002/mdc3.70244","DOIUrl":"10.1002/mdc3.70244","url":null,"abstract":"<p><strong>Background: </strong>MDS-UPDRS Severity Levels (SLs), derived from clinician- and patient-rated scales, remain underused to evaluate response to subthalamic deep brain stimulation (STN-DBS) in patients with Parkinson's disease (PD).</p><p><strong>Objectives: </strong>To evaluate MDS-UPDRS SL as markers of STN-DBS response.</p><p><strong>Methods: </strong>SLs were categorized as mild, moderate, or severe using established cut-off points for Parts II, III Off, and IV. Improvement was defined as a decrease in at least one SL. Part III Off improvement was correlated to quality-of-life scales and used to predict SL improvement using ROC Curve analysis.</p><p><strong>Results: </strong>A total of 51 patients (34.1% female, aged 58.9 ± 10.2 years, disease duration 12.3 ± 4.1 years) were evaluated 12 months after surgery. MDS-UPDRS III Off changes over 30% predicted SL improvements in MDS-UPDRS II (AUC = 0.83, p = 0.015) and IV (AUC = 0.89, p = 0.001).</p><p><strong>Conclusion: </strong>Our findings suggest that improvement in MDS-UPDRS SL are potential markers of STN-DBS response. With an MDS-UPDRS part III improvement around 30% predicting SL improvement.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2324-2329"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144962029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One Side or Two? A Systematic Review of Deep Brain Stimulation Approaches in Movement Disorders. 一面还是两面?脑深部刺激治疗运动障碍的系统综述。
IF 2.7 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-08-14 DOI: 10.1002/mdc3.70274
Artur Vetkas, Andrew Yang, Alexandre Boutet, Cletus Cheyuo, Brendan Santyr, Can Sarica, Benjamin Davidson, Anton Fomenko, Nardin Samuel, Stefan Lang, Srdjan Sumarac, Luka Milosevic, Taufik Valiante, Mojgan Hodaie, Suneil K Kalia, Andres M Lozano

Background: Deep brain stimulation (DBS) is an established treatment for movement disorders such as Parkinson's disease (PD) and essential tremor (ET). However, the decision between unilateral, staged bilateral, or simultaneous bilateral DBS remains controversial, influenced by clinical presentation, patient preferences, and economic factors.

Objective: The aim was to compare motor score improvements, adverse events (AE), incremental benefits, and progression with unilateral to bilateral procedures and the rationale for second-side surgery.

Methods: This systematic review examined studies on patients treated with unilateral or bilateral (simultaneous or staged) DBS from 1999 to 2025, focusing on outcomes, safety, and efficacy.

Results: In PD, unilateral DBS targeting the subthalamic nucleus (STN) or globus pallidus internus (GPi) improves motor scores by up to 37%, whereas bilateral DBS yields improvements of up to 66%. Unilateral DBS provides up to 75% improvement in contralateral symptoms but only up to 28% in ipsilateral symptoms. More than half of PD patients eventually opt for second-side surgery due to worsening symptoms. In ET, unilateral ventral intermediate nucleus (VIM) DBS improves hand tremor by up to 89%, with staged bilateral procedures offering an additional 77% to 89% improvement contralaterally. Axial tremor improves by up to 60% with unilateral VIM DBS and a further 60% after bilateral surgery. Bilateral VIM DBS is linked to more AEs, such as gait disorders and dysarthria, whereas STN and GPi DBS have comparable risks. Staged surgeries are associated with longer surgical times and increased revisions and programming.

Conclusions: Individualized treatment decisions are essential, with bilateral DBS providing superior long-term outcomes for both PD and ET.

背景:脑深部电刺激(DBS)是帕金森病(PD)和特发性震颤(ET)等运动障碍的有效治疗方法。然而,单侧、分阶段双侧或同时双侧DBS的决定仍然存在争议,受临床表现、患者偏好和经济因素的影响。目的:目的是比较单侧到双侧手术的运动评分改善、不良事件(AE)、增量获益和进展,以及第二侧手术的基本原理。方法:本系统综述从1999年到2025年对单侧或双侧(同时或分阶段)DBS治疗的患者进行了研究,重点关注结果、安全性和有效性。结果:在PD中,针对丘脑下核(STN)或内苍白球(GPi)的单侧DBS可使运动评分提高37%,而双侧DBS可使运动评分提高66%。单侧DBS对对侧症状的改善可达75%,但对同侧症状的改善仅为28%。由于症状恶化,超过一半的PD患者最终选择第二侧手术。在ET中,单侧腹侧中间核(VIM) DBS可改善手部震颤高达89%,分阶段双侧手术可对侧额外改善77%至89%。单侧VIM DBS可使轴性震颤改善60%,双侧手术后可进一步改善60%。双侧VIM DBS与更多ae相关,如步态障碍和构音障碍,而STN和GPi DBS的风险相当。分阶段手术与更长的手术时间、更多的修正和规划有关。结论:个性化的治疗决策是必要的,双侧DBS为PD和ET提供了优越的长期疗效。
{"title":"One Side or Two? A Systematic Review of Deep Brain Stimulation Approaches in Movement Disorders.","authors":"Artur Vetkas, Andrew Yang, Alexandre Boutet, Cletus Cheyuo, Brendan Santyr, Can Sarica, Benjamin Davidson, Anton Fomenko, Nardin Samuel, Stefan Lang, Srdjan Sumarac, Luka Milosevic, Taufik Valiante, Mojgan Hodaie, Suneil K Kalia, Andres M Lozano","doi":"10.1002/mdc3.70274","DOIUrl":"10.1002/mdc3.70274","url":null,"abstract":"<p><strong>Background: </strong>Deep brain stimulation (DBS) is an established treatment for movement disorders such as Parkinson's disease (PD) and essential tremor (ET). However, the decision between unilateral, staged bilateral, or simultaneous bilateral DBS remains controversial, influenced by clinical presentation, patient preferences, and economic factors.</p><p><strong>Objective: </strong>The aim was to compare motor score improvements, adverse events (AE), incremental benefits, and progression with unilateral to bilateral procedures and the rationale for second-side surgery.</p><p><strong>Methods: </strong>This systematic review examined studies on patients treated with unilateral or bilateral (simultaneous or staged) DBS from 1999 to 2025, focusing on outcomes, safety, and efficacy.</p><p><strong>Results: </strong>In PD, unilateral DBS targeting the subthalamic nucleus (STN) or globus pallidus internus (GPi) improves motor scores by up to 37%, whereas bilateral DBS yields improvements of up to 66%. Unilateral DBS provides up to 75% improvement in contralateral symptoms but only up to 28% in ipsilateral symptoms. More than half of PD patients eventually opt for second-side surgery due to worsening symptoms. In ET, unilateral ventral intermediate nucleus (VIM) DBS improves hand tremor by up to 89%, with staged bilateral procedures offering an additional 77% to 89% improvement contralaterally. Axial tremor improves by up to 60% with unilateral VIM DBS and a further 60% after bilateral surgery. Bilateral VIM DBS is linked to more AEs, such as gait disorders and dysarthria, whereas STN and GPi DBS have comparable risks. Staged surgeries are associated with longer surgical times and increased revisions and programming.</p><p><strong>Conclusions: </strong>Individualized treatment decisions are essential, with bilateral DBS providing superior long-term outcomes for both PD and ET.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2080-2091"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144855865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease. 帕金森病患者口服多巴胺能治疗突然中断时,皮下Foslevodopa作为抢救疗法。
IF 2.7 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-07-24 DOI: 10.1002/mdc3.70253
Fabienne Ory-Magne, Jean Luc Houeto, Margherita Fabbri
{"title":"Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease.","authors":"Fabienne Ory-Magne, Jean Luc Houeto, Margherita Fabbri","doi":"10.1002/mdc3.70253","DOIUrl":"10.1002/mdc3.70253","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2382-2385"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715331/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144699102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Various Gait Patterns in Chorea-Acanthocytosis. 舞蹈病-棘细胞增多症的不同步态模式。
IF 2.7 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-07-11 DOI: 10.1002/mdc3.70235
Sepehr Khosravi, Gholamali Shahidi, Anthony E Lang, Mohammad Rohani
{"title":"Various Gait Patterns in Chorea-Acanthocytosis.","authors":"Sepehr Khosravi, Gholamali Shahidi, Anthony E Lang, Mohammad Rohani","doi":"10.1002/mdc3.70235","DOIUrl":"10.1002/mdc3.70235","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2366-2367"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144619157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three-Week Video- and Home-Based Training Program for People with Ataxia: A Pilot Randomized Controlled Trial. 针对共济失调患者的三周视频和家庭培训计划:一项随机对照试验。
IF 2.7 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-07-14 DOI: 10.1002/mdc3.70225
Clara Rentz, Alisha Reinhardt, Naomi Jung, Vignesh Vanchinathan, Jutta Peterburs, Heike Jacobi, Dagmar Timmann, Andreas Thieme, Doris Brötz, Christian Bellebaum, Alfons Schnitzler, Katrin Amunts, Martina Minnerop

Background: Gait and balance impairment is a disabling clinical feature in people with degenerative cerebellar ataxia.

Objectives: We performed a rater-blinded, parallel 3-arm randomized controlled trial with delayed-start-design (exploratory proof-of-concept study) to assess whether, compared to control, people with mild/moderate hereditary ataxia benefit from additional video-based training with different frequencies, and how clinical characteristics interact with training success.

Methods: Digital gait/balance measures were assessed before and after a three-week video-based training program at home (Train20: 4 × 20min/week, n = 11; Train40: 2 × 40min/week, n = 11; control: standard medical care, n = 10). Group differences at baseline and changes over time were assessed using ANOVA. Linear mixed models were conducted to examine the influence of clinical variables on outcomes over time. Further exploratory analyses were performed using intraclass correlation coefficients (ICC), and paired t-tests within each group.

Results: All variables showed good to excellent test-retest reliability (ICC ≥0.69). No significant interactions between group and measurement time were found for clinical or gait/balance variables (p ≥ 0.338). However, participants with higher initial disease severity, greater impairment in activities of daily living, and better well-being showed significant improvements in feet-together stance (p = 0.04), normal (p = 0.01), and backward gait (p = 0.03). Exploratory analyses showed improvement only in Train40.

Conclusions: Although the protocol did not lead to general improvements in people with mild/moderate ataxia, irrespective of training frequency, those with higher initial disease severity, higher functional impairment, and better mental well-being showed significant benefits. Greater attention should be given to the impact of well-being to enhance motor training outcomes. Longer, less frequent sessions may offer greater potential for improvement.

背景:步态和平衡障碍是退行性小脑共济失调患者的一种致残性临床特征。目的:我们进行了一项非盲法、平行三组随机对照试验,采用延迟启动设计(探索性概念验证研究),以评估与对照组相比,轻度/中度遗传性共济失调患者是否从不同频率的额外视频训练中获益,以及临床特征如何与训练成功相互作用。方法:在为期三周的家庭视频训练计划(Train20: 4 × 20分钟/周,n = 11;Train40: 2 × 40min/周,n = 11;对照组:标准医疗护理,n = 10)。采用方差分析评估各组基线差异和随时间变化。采用线性混合模型来检验临床变量对结果的影响。进一步使用类内相关系数(ICC)进行探索性分析,并在每组内进行配对t检验。结果:所有变量的重测信度均为良至优(ICC≥0.69)。临床或步态/平衡变量与测量时间之间无显著交互作用(p≥0.338)。然而,初始疾病严重程度较高、日常生活活动受损较大、健康状况较好的参与者在双脚合十站立(p = 0.04)、正常步态(p = 0.01)和后退步态(p = 0.03)方面均有显著改善。探索性分析显示,只有Train40有所改善。结论:尽管该方案没有导致轻度/中度共济失调患者的普遍改善,无论训练频率如何,但那些初始疾病严重程度较高、功能损害较高和精神健康状况较好的患者显示出显着的益处。应该更多地关注幸福感的影响,以提高运动训练的效果。更长的、更少的会话可能提供更大的改进潜力。
{"title":"Three-Week Video- and Home-Based Training Program for People with Ataxia: A Pilot Randomized Controlled Trial.","authors":"Clara Rentz, Alisha Reinhardt, Naomi Jung, Vignesh Vanchinathan, Jutta Peterburs, Heike Jacobi, Dagmar Timmann, Andreas Thieme, Doris Brötz, Christian Bellebaum, Alfons Schnitzler, Katrin Amunts, Martina Minnerop","doi":"10.1002/mdc3.70225","DOIUrl":"10.1002/mdc3.70225","url":null,"abstract":"<p><strong>Background: </strong>Gait and balance impairment is a disabling clinical feature in people with degenerative cerebellar ataxia.</p><p><strong>Objectives: </strong>We performed a rater-blinded, parallel 3-arm randomized controlled trial with delayed-start-design (exploratory proof-of-concept study) to assess whether, compared to control, people with mild/moderate hereditary ataxia benefit from additional video-based training with different frequencies, and how clinical characteristics interact with training success.</p><p><strong>Methods: </strong>Digital gait/balance measures were assessed before and after a three-week video-based training program at home (Train20: 4 × 20min/week, n = 11; Train40: 2 × 40min/week, n = 11; control: standard medical care, n = 10). Group differences at baseline and changes over time were assessed using ANOVA. Linear mixed models were conducted to examine the influence of clinical variables on outcomes over time. Further exploratory analyses were performed using intraclass correlation coefficients (ICC), and paired t-tests within each group.</p><p><strong>Results: </strong>All variables showed good to excellent test-retest reliability (ICC ≥0.69). No significant interactions between group and measurement time were found for clinical or gait/balance variables (p ≥ 0.338). However, participants with higher initial disease severity, greater impairment in activities of daily living, and better well-being showed significant improvements in feet-together stance (p = 0.04), normal (p = 0.01), and backward gait (p = 0.03). Exploratory analyses showed improvement only in Train40.</p><p><strong>Conclusions: </strong>Although the protocol did not lead to general improvements in people with mild/moderate ataxia, irrespective of training frequency, those with higher initial disease severity, higher functional impairment, and better mental well-being showed significant benefits. Greater attention should be given to the impact of well-being to enhance motor training outcomes. Longer, less frequent sessions may offer greater potential for improvement.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2154-2167"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144626759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discontinuation of the Clozapine Risk Evaluation and Mitigation Strategy and Implications in Movement Disorders. 停用氯氮平的风险评估和缓解策略及其对运动障碍的影响。
IF 2.7 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-06-28 DOI: 10.1002/mdc3.70197
Charles Palmer, Alexander McClanahan, Federico Rodriguez-Porcel
{"title":"Discontinuation of the Clozapine Risk Evaluation and Mitigation Strategy and Implications in Movement Disorders.","authors":"Charles Palmer, Alexander McClanahan, Federico Rodriguez-Porcel","doi":"10.1002/mdc3.70197","DOIUrl":"10.1002/mdc3.70197","url":null,"abstract":"","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2106-2110"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715328/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Inner Sense to Outer Action: Interoception and Impulsive Compulsive Behavior Disorders in Parkinson's Disease. 从内在感觉到外在行为:帕金森氏病的内感受和冲动强迫行为障碍。
IF 2.7 4区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2025-12-01 Epub Date: 2025-06-23 DOI: 10.1002/mdc3.70187
Chiara Baiano, Francesca Morgante, Diana Goeta, Chiara Giacobbe, Marianna Amboni, Carmine Vitale, Elena Makovac, Benedetta Demartini, Gabriella Santangelo, Lucia Ricciardi

Background: Impulsive-compulsive behavior disorders (ICBDs) in Parkinson's disease (PD) include impulse control disorders (ICDs) and compulsive behaviors, often linked to dopaminergic treatment and altered reward processing. Interoception, the perception of internal bodily signals, plays a key role in emotional regulation and decision-making. Neuroimaging studies suggest that alterations in interoceptive and reward-related brain circuits may underlie ICDs in PD. However, the relationship between interoception and ICDs remains underexplored.

Objective: To investigate the relationship between impulse control disorders (ICD) severity and interoceptive abilities-specifically interoceptive accuracy, insight, and self-reported interoception-in PD patients.

Methods: Fifty-one participants were assessed using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale (QUIP-RS) alongside measures of interoceptive performance, anxiety, depression, and apathy.

Results: Higher ICD severity predicted increased interoceptive insight and sensibility. No significant link was found between ICD severity and interoceptive accuracy. Additionally, higher Levodopa Equivalent Daily Dose (LEDD) was related to lower interoceptive insight, suggesting a potential modulatory effect of dopaminergic therapy on meta-cognitive interoception.

Conclusions: These findings highlight the complex interplay between ICDs and interoception, suggesting that heightened self-reported interoception and interoceptive insight may reinforce impulsive behaviors in PD via enhanced bodily signal salience. This study contributes to understanding the characteristics of ICDs in PD, implicating reward-related circuits such as the insula and anterior cingulate cortex.

背景:帕金森病(PD)的冲动强迫行为障碍(icbd)包括冲动控制障碍(ICDs)和强迫行为,通常与多巴胺能治疗和奖励加工改变有关。内感受是对身体内部信号的感知,在情绪调节和决策中起着关键作用。神经影像学研究表明,内部感受性和奖励相关脑回路的改变可能是PD中icd的基础。然而,内感受与icd之间的关系仍未得到充分探讨。目的:探讨PD患者冲动控制障碍(ICD)严重程度与内感受能力(特别是内感受准确性、洞察力和自述内感受)之间的关系。方法:采用帕金森病冲动性强迫症评定量表(QUIP-RS)和内感受性表现、焦虑、抑郁和冷漠量表对51名参与者进行评估。结果:较高的ICD严重程度预示着内感受性洞察力和敏感性的增加。没有发现ICD严重程度和内感受准确性之间的显著联系。此外,较高的左旋多巴当量日剂量(LEDD)与较低的内感受洞察力相关,表明多巴胺能治疗对元认知内感受有潜在的调节作用。结论:这些发现强调了icd与内感受之间复杂的相互作用,表明自我报告的内感受和内感受顿悟可能通过增强身体信号显著性来强化PD患者的冲动行为。这项研究有助于理解PD中ICDs的特征,包括脑岛和前扣带皮层等与奖励相关的回路。
{"title":"From Inner Sense to Outer Action: Interoception and Impulsive Compulsive Behavior Disorders in Parkinson's Disease.","authors":"Chiara Baiano, Francesca Morgante, Diana Goeta, Chiara Giacobbe, Marianna Amboni, Carmine Vitale, Elena Makovac, Benedetta Demartini, Gabriella Santangelo, Lucia Ricciardi","doi":"10.1002/mdc3.70187","DOIUrl":"10.1002/mdc3.70187","url":null,"abstract":"<p><strong>Background: </strong>Impulsive-compulsive behavior disorders (ICBDs) in Parkinson's disease (PD) include impulse control disorders (ICDs) and compulsive behaviors, often linked to dopaminergic treatment and altered reward processing. Interoception, the perception of internal bodily signals, plays a key role in emotional regulation and decision-making. Neuroimaging studies suggest that alterations in interoceptive and reward-related brain circuits may underlie ICDs in PD. However, the relationship between interoception and ICDs remains underexplored.</p><p><strong>Objective: </strong>To investigate the relationship between impulse control disorders (ICD) severity and interoceptive abilities-specifically interoceptive accuracy, insight, and self-reported interoception-in PD patients.</p><p><strong>Methods: </strong>Fifty-one participants were assessed using the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale (QUIP-RS) alongside measures of interoceptive performance, anxiety, depression, and apathy.</p><p><strong>Results: </strong>Higher ICD severity predicted increased interoceptive insight and sensibility. No significant link was found between ICD severity and interoceptive accuracy. Additionally, higher Levodopa Equivalent Daily Dose (LEDD) was related to lower interoceptive insight, suggesting a potential modulatory effect of dopaminergic therapy on meta-cognitive interoception.</p><p><strong>Conclusions: </strong>These findings highlight the complex interplay between ICDs and interoception, suggesting that heightened self-reported interoception and interoceptive insight may reinforce impulsive behaviors in PD via enhanced bodily signal salience. This study contributes to understanding the characteristics of ICDs in PD, implicating reward-related circuits such as the insula and anterior cingulate cortex.</p>","PeriodicalId":19029,"journal":{"name":"Movement Disorders Clinical Practice","volume":" ","pages":"2253-2259"},"PeriodicalIF":2.7,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12715371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144369091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Movement Disorders Clinical Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1